Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD

biospectrumasiaApril 29, 2019

Tag: Acadia Pharma , Ph3 CLARITY , Pimavanserin

PharmaSources Customer Service